Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children

PHASE3CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

May 13, 2025

Study Completion Date

May 13, 2025

Conditions
Peanut Allergy
Interventions
BIOLOGICAL

DBV712 250 mcg

DBV712 250 mcg, once daily

Trial Locations (26)

10029

Mount Sinai Medical Center, New York

14642

University of Rochester, Rochester

15224

UPMC Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

20010

Children's National Health Center, Washington D.C.

21205

Johns Hopkins Hospital, Baltimore

27599

The University of North Carolina - Chapell Hill, Chapel Hill

30329

Children's Healthcare of Atlanta, Atlanta

37204

Vanderbilt University Medical Center, Nashville

38105

Le Bonheur Children's Hospital, Memphis

46202

Riley Hospital for Children, Indianapolis

48106

University of Michigan - Allergy Specialty Clinic and Food Allergy Clinic, Ann Arbor

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

60637

Comer Children's Hospital, Chicago

72202

Arkansas Children's Hospital, Little Rock

75235

Children's Medical Center Dallas, Dallas

77030

Baylor College of Medicine, Houston

78723

Dell Children's Medical Center of Central Texas, Austin

80045

Children's Hospital Colorado, Aurora

90095

David Geffen School of Medicine at University of California Los Angeles, Los Angeles

92123

Rady Children's Hospital San Diego, San Diego

94158

University of California San Francisco, San Francisco

94305

Stanford University School of Medicine, Stanford

98115

Seattle Allergy & Asthma Research Institute, Seattle

85724-5030

Banner University Medical Center Tucson, Tucson

02115

Boston Childrens' Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

DBV Technologies

INDUSTRY

NCT03859700 - Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children | Biotech Hunter | Biotech Hunter